Oonk, M. H. et al. Size of sentinel-node metastasis and chances of non-sentinel-node involvement and survival in early stage vulvar cancer: results from GROINSS-V, a multicentre observational study. Lancet Oncol. 11, 646–652 (2010).
Ballester, M. et al. Detection rate and diagnostic accuracy of sentinel-node biopsy in early stage endometrial cancer: a prospective multicentre study (SENTI-ENDO). Lancet Oncol. 12, 469–476 (2011).
Cusimano, M. C. et al. Assessment of sentinel lymph node biopsy vs lymphadenectomy for intermediate- and high-grade endometrial cancer staging. JAMA Surg. 156, 157–164 (2021).
Rossi, E. C. et al. A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study. Lancet Oncol. 18, 384–392 (2017).
Soliman, P. T. et al. A prospective validation study of sentinel lymph node mapping for high-risk endometrial cancer. Gynecol. Oncol. 146, 234–239 (2017).
Article PubMed PubMed Central Google Scholar
National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines), Cervical Cancer. Version 2.2024. https://www.nccn.org/professionals/physician_gls/pdf/cervical.pdf (2024).
Cibula, D. et al. The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology guidelines for the management of patients with cervical cancer. Int. J. Gynecol. Cancer 28, 641–655 (2018).
Cibula, D. et al. ESGO/ESTRO/ESP guidelines for the management of patients with cervical cancer - update 2023. Int. J. Gynecol. Cancer 33, 649–666 (2023).
Article PubMed PubMed Central Google Scholar
Margioula-Siarkou, C. et al. Sentinel lymph node staging in early-stage cervical cancer: a comprehensive review. J. Clin. Med. https://doi.org/10.3390/jcm13010027 (2023).
Ronsini, C. et al. The oncological implication of sentinel lymph node in early cervical cancer: a meta-analysis of oncological outcomes and type of recurrences. Medicina https://doi.org/10.3390/medicina58111539 (2022).
Dundr, P. et al. Pathologic protocols for sentinel lymph nodes ultrastaging in cervical cancer. Arch. Pathol. Lab. Med. https://doi.org/10.5858/arpa.2019-0249-RA (2019).
Mauro, J. et al. Survival after sentinel node biopsy alone in early-stage cervical cancer: a systematic review. Int. J. Gynecol. Cancer 33, 1370–1375 (2023).
Cibula, D. et al. The annual recurrence risk model for tailored surveillance strategy in patients with cervical cancer. Eur. J. Cancer 158, 111–122 (2021).
Article PubMed PubMed Central Google Scholar
Chiva, L. SUCCOR study: an international European cohort observational study comparing minimally invasive surgery versus open abdominal radical hysterectomy in patients with stage IB1 cervical cancer. Int. J. Gynecol. Cancer 30, 449–450 (2020).
Mathevet, P. et al. Sentinel lymph node biopsy and morbidity outcomes in early cervical cancer: results of a multicentre randomised trial (SENTICOL-2). Eur. J. Cancer 148, 307–315 (2021).
Ramirez, P. T. et al. Minimally invasive versus abdominal radical hysterectomy for cervical cancer. New Engl. J. Med. 379, 1895–1904 (2018).
Plante, M. et al. Simple versus radical hysterectomy in women with low-risk cervical cancer. New Engl. J. Med. 390, 819–829 (2024).
Schmeler, K. M. et al. ConCerv: a prospective trial of conservative surgery for low-risk early-stage cervical cancer. Int. J. Gynecol. Cancer 31, 1317–1325 (2021).
Article PubMed PubMed Central Google Scholar
Kocian, R. et al. Sentinel lymph node pathological ultrastaging: final outcome of the SENTIX prospective international study in patients with early-stage cervical cancer. Gynecol. Oncol. 188, 83–89 (2024).
Lecuru, F. R. et al. SENTICOL III: an international validation study of sentinel node biopsy in early cervical cancer. A GINECO, ENGOT, GCIG and multicenter study. Int. J. Gynecol. Cancer 29, 829–834 (2019).
Article PubMed PubMed Central Google Scholar
Tu, H. et al. Sentinel lymph node biopsy versus pelvic lymphadenectomy in early-stage cervical cancer: a multi-center randomized trial (PHENIX/CSEM 010). Int. J. Gynecol. Cancer 30, 1829–1833 (2020).
Vergote, I. et al. European Network of Gynaecological Oncological Trial Groups’ requirements for trials between academic groups and pharmaceutical companies. Int. J. Gynecol. Cancer 20, 476–478 (2010).
Cibula, D. et al. A prospective multicenter trial on sentinel lymph node biopsy in patients with early-stage cervical cancer (SENTIX). Int. J. Gynecol. Cancer 29, 212–215 (2019).
Cibula, D. et al. Sentinel lymph node mapping and intraoperative assessment in a prospective, international, multicentre, observational trial of patients with cervical cancer: the SENTIX trial. Eur. J. Cancer 137, 69–80 (2020).
Pecorelli, S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int. J. Gynaecol. Obstet. 105, 103–104 (2009).
Querleu, D., Cibula, D. & Abu-Rustum, N. R. 2017 update on the Querleu-Morrow classification of radical hysterectomy. Ann. Surg. Oncol. 24, 3406–3412 (2017).
Article PubMed PubMed Central Google Scholar
Nemejcova, K. et al. Central pathology review in SENTIX, a prospective observational international study on sentinel lymph node biopsy in patients with early-stage cervical cancer (ENGOT-CX2). Cancers https://doi.org/10.3390/cancers12051115 (2020).
Borčinová, M. et al. Challenges in lower limb lymphoedema assessment based on limb volume change: lessons learnt from the SENTIX prospective multicentre study. Gynecol. Oncol. 164, 76–84 (2022).
Zapardiel, I. et al. Voiding recovery after radical parametrectomy in cervical cancer patients: an international prospective multicentre trial - SENTIX. Gynecol. Oncol. 160, 729–734 (2021).
Cibula, D. et al. Bilateral ultrastaging of sentinel lymph node in cervical cancer: lowering the false-negative rate and improving the detection of micrometastasis. Gynecol. Oncol. 127, 462–466 (2012).
Cibula, D. et al. Prognostic significance of low volume sentinel lymph node disease in early-stage cervical cancer. Gynecol. Oncol. 124, 496–501 (2012).
Article CAS PubMed Google Scholar
Ayhan, A. et al. Prognostic factors in FIGO stage IB cervical cancer without lymph node metastasis and the role of adjuvant radiotherapy after radical hysterectomy. Int. J. Gynecol. Cancer 14, 286–292 (2004).
Article CAS PubMed Google Scholar
Bodurka-Bevers, D. et al. Posttherapy surveillance of women with cervical cancer: an outcomes analysis. Gynecol. Oncol. 78, 187–193 (2000).
Article CAS PubMed Google Scholar
Chittithaworn, S., Hanprasertpong, J., Tungsinmunkong, K. & Geater, A. Association between prognostic factors and disease-free survival of cervical cancer stage IB1 patients undergoing radical hysterectomy. Asian Pac. J. Cancer Prev. 8, 530–534 (2007).
Hoogendam, J. P., Verheijen, R. H., Wegner, I. & Zweemer, R. P. Oncological outcome and long-term complications in robot-assisted radical surgery for early stage cervical cancer: an observational cohort study. BJOG 121, 1538–1545 (2014).
Article CAS PubMed Google Scholar
Landoni, F. et al. Class II versus class III radical hysterectomy in stage IB-IIA cervical cancer: a prospective randomized study. Gynecol. Oncol. 80, 3–12 (2001).
Article CAS PubMed Google Scholar
Laterza, R. M. et al. Recurrence of early stage cervical cancer after laparoscopic versus open radical surgery. Int. J. Gynecol. Cancer 26, 547–552 (2016).
Lee, C. L., Wu, K. Y., Huang, K. G., Lee, P. S. & Yen, C. F. Long-term survival outcomes of laparoscopically assisted radical hysterectomy in treating early-stage cervical cancer. Am. J. Obstet. Gynecol. 203, 165.e161–167 (2010).
Comments (0)